Margenza® (margetuximab-cmkb)
for Breast Cancer

Margenza (margetuximab-cmkb) is a HER2 inhibitor used to treat metastatic HER2-positive breast cancer. It is given in combination with other cancer drugs and is intended for patients who have received at least two prior chemotherapy treatments. Margenza works by slowing or stopping the growth of HER2-positive cancer cells.

Heart
Other top medicines used to treat Breast Cancer